On April 10, 2014 the U.S. Food & Drug Administration (FDA) issued a “Closeout” letter to Prodigy Diabetes Care to formally conclude the regulatory action that resulted in a Warning Letter on February 22, 2013.
Read more
DiabetesHealth – Prodigy Diabetes Care Moves Forward After FDA Concludes Regulatory Action
Posted in Glucose & Insulin